ATE301120T1 - Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid - Google Patents

Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid

Info

Publication number
ATE301120T1
ATE301120T1 AT97950663T AT97950663T ATE301120T1 AT E301120 T1 ATE301120 T1 AT E301120T1 AT 97950663 T AT97950663 T AT 97950663T AT 97950663 T AT97950663 T AT 97950663T AT E301120 T1 ATE301120 T1 AT E301120T1
Authority
AT
Austria
Prior art keywords
dihydroxycyclopentancarboxamide
thien
imidazo
pyridine
chloro
Prior art date
Application number
AT97950663T
Other languages
English (en)
Inventor
Michael K O'brien
Herve Garcia
Patrick Leon
Tory H Powner
Laurence W Reilly
Harshavadan C Shah
Michael D Thompson
Ching T Tsuei
Benoit J Vanasse
Francis L Walther
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE301120T1 publication Critical patent/ATE301120T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT97950663T 1996-12-11 1997-11-24 Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid ATE301120T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3276496P 1996-12-11 1996-12-11
PCT/US1997/021439 WO1998025921A1 (en) 1996-12-11 1997-11-24 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE

Publications (1)

Publication Number Publication Date
ATE301120T1 true ATE301120T1 (de) 2005-08-15

Family

ID=21866680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950663T ATE301120T1 (de) 1996-12-11 1997-11-24 Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid

Country Status (26)

Country Link
US (2) US6143894A (de)
EP (2) EP0946550B1 (de)
JP (1) JP2001506626A (de)
KR (4) KR100510389B1 (de)
CN (3) CN1191251C (de)
AP (1) AP1063A (de)
AT (1) ATE301120T1 (de)
AU (1) AU738581B2 (de)
BG (1) BG63805B1 (de)
BR (1) BR9713705A (de)
CA (1) CA2274630C (de)
DE (1) DE69733897T2 (de)
DK (1) DK0946550T3 (de)
EA (1) EA001989B1 (de)
ES (1) ES2242984T3 (de)
HU (1) HUP0000342A3 (de)
IL (1) IL130397A (de)
MX (1) MXPA03006730A (de)
NO (2) NO319722B1 (de)
OA (1) OA11061A (de)
PT (1) PT946550E (de)
SI (1) SI0946550T1 (de)
SK (1) SK71199A3 (de)
UA (1) UA54479C2 (de)
WO (1) WO1998025921A1 (de)
ZA (1) ZA9711035B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1140933E (pt) 1998-12-31 2004-12-31 Aventis Pharma Inc Processo para preparar derivados n6-substituidos de desaza-adenosina
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
FR2846656B1 (fr) * 2002-11-05 2004-12-24 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU654507B2 (en) * 1990-09-25 1994-11-10 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
PL337888A1 (en) * 1997-07-03 2000-09-11 Du Pont Pharm Co Imidazoprimidines and imidazopyridines for use in treating neurological disorders
KR20010087425A (ko) * 1998-12-21 2001-09-15 오흘러 로스 제이. N6-치환된 데아자-아데노신 유도체의 제조방법

Also Published As

Publication number Publication date
AU738581B2 (en) 2001-09-20
US6235909B1 (en) 2001-05-22
EP0946550A1 (de) 1999-10-06
NO992795D0 (no) 1999-06-09
NO319722B1 (no) 2005-09-05
BG103484A (en) 2000-06-30
NO992795L (no) 1999-08-10
DK0946550T3 (da) 2005-08-29
AP1063A (en) 2002-04-26
HUP0000342A3 (en) 2001-01-29
HK1023998A1 (en) 2000-09-29
CN1240445A (zh) 2000-01-05
CN1191251C (zh) 2005-03-02
KR20000057505A (ko) 2000-09-15
PT946550E (pt) 2005-09-30
DE69733897D1 (de) 2005-09-08
CN1090630C (zh) 2002-09-11
KR100510389B1 (ko) 2005-08-31
MXPA03006730A (es) 2003-10-24
EA199900527A1 (ru) 2000-02-28
KR100571690B1 (ko) 2006-04-18
EP1609791A1 (de) 2005-12-28
WO1998025921A1 (en) 1998-06-18
IL130397A (en) 2005-11-20
HK1051862A1 (en) 2003-08-22
ZA9711035B (en) 1998-06-15
ES2242984T3 (es) 2005-11-16
HUP0000342A2 (hu) 2000-10-28
OA11061A (en) 2002-02-27
KR20060002030A (ko) 2006-01-06
CN1394859A (zh) 2003-02-05
BR9713705A (pt) 2000-05-09
BG63805B1 (bg) 2003-01-31
SI0946550T1 (en) 2005-10-31
EP0946550A4 (de) 2003-05-14
IL130397A0 (en) 2000-06-01
UA54479C2 (uk) 2003-03-17
US6143894A (en) 2000-11-07
NO20052327D0 (no) 2005-05-12
KR20050046793A (ko) 2005-05-18
NO20052327L (no) 1999-08-10
JP2001506626A (ja) 2001-05-22
SK71199A3 (en) 2000-07-11
CN1660842A (zh) 2005-08-31
CA2274630C (en) 2000-10-03
KR20060002029A (ko) 2006-01-06
EA001989B1 (ru) 2001-10-22
AP9901550A0 (en) 1999-06-30
AU5360798A (en) 1998-07-03
EP0946550B1 (de) 2005-08-03
DE69733897T2 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
NO20020832D0 (no) Imidazo(1,2-A)pyridin og pyrazolo(2,3-A)pyridin derivater
DE68911033D1 (de) Alkoxy-1,2,4-triazolo (1,5-c) pyrimidine-2-sulfonamide, Verfahren zu ihrer Herstellung und Zwischenprodukte.
IS4570A (is) Imidazó[1,2-a]pýridín afleiður
TR199800085A3 (tr) 8-Sübstitüye edilmis-1,3,8-triaza- spiro(4,5)dekan-4-on türevleri.
DK0931081T3 (da) Pyridazino-[4,5-B]-quinolin-5-oxid-derivater, deres fremstilling og deres anvendelse som glycinantagonister
BE888073A (fr) DERIVES D'IMIDAZO 4,5-b PYRIDINE LEUR PREPARATION ET LEUR UTILISATION COMME AGENTS CARDIOTONIQUES.
HUP9601240A1 (en) Pyridin and pyrimidin derivatives, suitable as beta-adrenerg agonists, pharmaceutical compositions containing the same and their intermediates
FI961564L (fi) Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit
AU7849387A (en) 2- or-3- aryl substituted imidazo(1,2-a)pyridines
ATE218567T1 (de) 1h-pyrido(3,4-b)indolcarboxamidderivate, ihre herstellung und therapeutische verwendung
NO874302D0 (no) Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner.
DE68919731D1 (de) Pyrimidin-Derivate, Verfahren zu deren Herstellung und diese enthaltende herbizide Zusammensetzungen.
ATE301120T1 (de) Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid
FI943294L (fi) Alkaloidit Mappia foetidasta, niiden käyttö, ja niitä sisältävät formulloinnit
DE69320668D1 (de) Verfahren zur Herstellung von Imidazo(4,5-b)Pyridinderivaten
DE59006542D1 (de) 2,3-substituierte 1,8-Naphthyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidots.
DK33684D0 (da) Pyrazino (2',3'-3,4)pyrido(1,2-a)-indol-derivater
TR28699A (tr) Imidazopiridin türevlerinin hazirlanmasi icin yöntem.
DE68913338D1 (de) 5-Fluormethyl-1,2,4-triazolo(1,5-a)pyrimidin-2-sulfonamide, Verfahren zu ihrer Herstellung und Zubereitungen als Herbizide.
ZA873507B (en) Pyrazolo(3,4-b)pyridine derivatives,processes and intermediate stages for their preparation and their use as herbicides
EE9400439A (et) Naftüridiini derivaadid, nende valmistamise meetodid, neid sisaldavad ravimvormid, eriti kasutamiseks antiproliferatiivsete preparaatidena
EE200000029A (et) 5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid
DE3776199D1 (de) 2,3-dihydro-1-(8-methyl-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4(1h)-pyridinon.
FI943706A7 (fi) Menetelmä kiraalisen etyyli-(5-amino-1,2-dihydro-2-metyyli-3-fenyylipyrido(3,4-b)pyratsin-7-yyli)karbamaatin valmistamiseksi
ATE102202T1 (de) 5-fluormethyl-1,2,4-triazolo(1,5-a)pyrimidin-2sulfonamide, verfahren zu ihrer herstellung und zubereitungen als herbizide.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0946550

Country of ref document: EP

REN Ceased due to non-payment of the annual fee